nodes	percent_of_prediction	percent_of_DWPC	metapath
Paliperidone—CYP3A5—Dapsone—systemic lupus erythematosus	0.0625	0.136	CbGbCtD
Paliperidone—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0542	0.118	CbGbCtD
Paliperidone—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0435	0.0943	CbGbCtD
Paliperidone—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0411	0.0891	CbGbCtD
Paliperidone—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0279	0.0605	CbGbCtD
Paliperidone—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.0271	0.0587	CbGbCtD
Paliperidone—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0252	0.0546	CbGbCtD
Paliperidone—HTR2C—choroid plexus—systemic lupus erythematosus	0.0252	0.217	CbGeAlD
Paliperidone—CYP3A4—Dapsone—systemic lupus erythematosus	0.0244	0.0529	CbGbCtD
Paliperidone—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0211	0.0458	CbGbCtD
Paliperidone—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0211	0.0458	CbGbCtD
Paliperidone—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0181	0.0393	CbGbCtD
Paliperidone—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0179	0.0388	CbGbCtD
Paliperidone—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.017	0.0368	CbGbCtD
Paliperidone—CYP3A4—Prednisone—systemic lupus erythematosus	0.0169	0.0366	CbGbCtD
Paliperidone—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.0166	0.036	CbGbCtD
Paliperidone—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.016	0.0347	CbGbCtD
Paliperidone—HTR2A—choroid plexus—systemic lupus erythematosus	0.0126	0.109	CbGeAlD
Paliperidone—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0105	0.0229	CbGbCtD
Paliperidone—HTR2A—urine—systemic lupus erythematosus	0.00338	0.0291	CbGeAlD
Paliperidone—CYP3A4—urine—systemic lupus erythematosus	0.00313	0.027	CbGeAlD
Paliperidone—CYP2D6—urine—systemic lupus erythematosus	0.00308	0.0265	CbGeAlD
Paliperidone—HTR1A—blood plasma—systemic lupus erythematosus	0.00296	0.0255	CbGeAlD
Paliperidone—ADRA1B—kidney—systemic lupus erythematosus	0.0022	0.019	CbGeAlD
Paliperidone—CYP3A5—blood plasma—systemic lupus erythematosus	0.00217	0.0187	CbGeAlD
Paliperidone—ADRA2A—blood plasma—systemic lupus erythematosus	0.00207	0.0179	CbGeAlD
Paliperidone—HTR2A—endothelium—systemic lupus erythematosus	0.00198	0.0171	CbGeAlD
Paliperidone—HTR1D—connective tissue—systemic lupus erythematosus	0.00189	0.0163	CbGeAlD
Paliperidone—DRD3—nervous system—systemic lupus erythematosus	0.00188	0.0162	CbGeAlD
Paliperidone—DRD3—central nervous system—systemic lupus erythematosus	0.00181	0.0156	CbGeAlD
Paliperidone—HTR2A—blood plasma—systemic lupus erythematosus	0.00176	0.0152	CbGeAlD
Paliperidone—CYP3A4—blood plasma—systemic lupus erythematosus	0.00163	0.0141	CbGeAlD
Paliperidone—HTR1D—kidney—systemic lupus erythematosus	0.00161	0.0139	CbGeAlD
Paliperidone—CYP2D6—blood plasma—systemic lupus erythematosus	0.00161	0.0138	CbGeAlD
Paliperidone—ADRA1B—nervous system—systemic lupus erythematosus	0.00144	0.0124	CbGeAlD
Paliperidone—ADRA1B—central nervous system—systemic lupus erythematosus	0.00139	0.012	CbGeAlD
Paliperidone—DRD1—nervous system—systemic lupus erythematosus	0.00134	0.0116	CbGeAlD
Paliperidone—ADRA2C—nephron tubule—systemic lupus erythematosus	0.00134	0.0116	CbGeAlD
Paliperidone—DRD1—central nervous system—systemic lupus erythematosus	0.00129	0.0112	CbGeAlD
Paliperidone—ADRA2C—kidney—systemic lupus erythematosus	0.00118	0.0102	CbGeAlD
Paliperidone—ADRA2C—cortex of kidney—systemic lupus erythematosus	0.00115	0.00989	CbGeAlD
Paliperidone—HRH1—connective tissue—systemic lupus erythematosus	0.00112	0.00969	CbGeAlD
Paliperidone—CYP3A5—nephron tubule—systemic lupus erythematosus	0.00112	0.00967	CbGeAlD
Paliperidone—ADRA2A—connective tissue—systemic lupus erythematosus	0.0011	0.00952	CbGeAlD
Paliperidone—HTR1B—nervous system—systemic lupus erythematosus	0.00109	0.0094	CbGeAlD
Paliperidone—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.00106	0.00915	CbGeAlD
Paliperidone—HTR1D—nervous system—systemic lupus erythematosus	0.00106	0.0091	CbGeAlD
Paliperidone—HTR1B—central nervous system—systemic lupus erythematosus	0.00105	0.00905	CbGeAlD
Paliperidone—HTR2C—nervous system—systemic lupus erythematosus	0.00104	0.00901	CbGeAlD
Paliperidone—HTR1D—central nervous system—systemic lupus erythematosus	0.00102	0.00876	CbGeAlD
Paliperidone—HTR2C—central nervous system—systemic lupus erythematosus	0.00101	0.00867	CbGeAlD
Paliperidone—CYP3A5—kidney—systemic lupus erythematosus	0.000985	0.0085	CbGeAlD
Paliperidone—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.00096	0.00828	CbGeAlD
Paliperidone—ADRA2C—tendon—systemic lupus erythematosus	0.000951	0.0082	CbGeAlD
Paliperidone—HTR2A—connective tissue—systemic lupus erythematosus	0.000938	0.00809	CbGeAlD
Paliperidone—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.000915	0.00789	CbGeAlD
Paliperidone—HTR1A—nervous system—systemic lupus erythematosus	0.000879	0.00758	CbGeAlD
Paliperidone—DRD2—lung—systemic lupus erythematosus	0.000858	0.0074	CbGeAlD
Paliperidone—HTR1A—central nervous system—systemic lupus erythematosus	0.000847	0.0073	CbGeAlD
Paliperidone—ADRA2C—lung—systemic lupus erythematosus	0.000834	0.00719	CbGeAlD
Paliperidone—ADRA1A—nervous system—systemic lupus erythematosus	0.000811	0.00699	CbGeAlD
Paliperidone—HTR2A—kidney—systemic lupus erythematosus	0.000799	0.00689	CbGeAlD
Paliperidone—DRD2—nervous system—systemic lupus erythematosus	0.000795	0.00685	CbGeAlD
Paliperidone—ADRA1A—central nervous system—systemic lupus erythematosus	0.00078	0.00673	CbGeAlD
Paliperidone—ADRA2C—nervous system—systemic lupus erythematosus	0.000772	0.00666	CbGeAlD
Paliperidone—HRH1—tendon—systemic lupus erythematosus	0.000772	0.00666	CbGeAlD
Paliperidone—DRD2—central nervous system—systemic lupus erythematosus	0.000765	0.0066	CbGeAlD
Paliperidone—ADRA2A—tendon—systemic lupus erythematosus	0.000758	0.00654	CbGeAlD
Paliperidone—ADRA2C—central nervous system—systemic lupus erythematosus	0.000744	0.00641	CbGeAlD
Paliperidone—CYP3A4—kidney—systemic lupus erythematosus	0.000739	0.00638	CbGeAlD
Paliperidone—CYP2D6—kidney—systemic lupus erythematosus	0.000728	0.00627	CbGeAlD
Paliperidone—CYP3A5—lung—systemic lupus erythematosus	0.000698	0.00602	CbGeAlD
Paliperidone—HRH1—lung—systemic lupus erythematosus	0.000678	0.00584	CbGeAlD
Paliperidone—ADRA2A—lung—systemic lupus erythematosus	0.000666	0.00574	CbGeAlD
Paliperidone—HTR2A—tendon—systemic lupus erythematosus	0.000645	0.00556	CbGeAlD
Paliperidone—HRH1—nervous system—systemic lupus erythematosus	0.000628	0.00541	CbGeAlD
Paliperidone—ADRA2A—nervous system—systemic lupus erythematosus	0.000616	0.00532	CbGeAlD
Paliperidone—HRH1—central nervous system—systemic lupus erythematosus	0.000604	0.00521	CbGeAlD
Paliperidone—ADRA2A—central nervous system—systemic lupus erythematosus	0.000593	0.00512	CbGeAlD
Paliperidone—HTR2A—lung—systemic lupus erythematosus	0.000566	0.00488	CbGeAlD
Paliperidone—HTR2A—nervous system—systemic lupus erythematosus	0.000524	0.00452	CbGeAlD
Paliperidone—HTR2A—central nervous system—systemic lupus erythematosus	0.000505	0.00435	CbGeAlD
Paliperidone—CYP3A4—nervous system—systemic lupus erythematosus	0.000485	0.00418	CbGeAlD
Paliperidone—CYP2D6—nervous system—systemic lupus erythematosus	0.000477	0.00412	CbGeAlD
Paliperidone—CYP3A4—central nervous system—systemic lupus erythematosus	0.000467	0.00403	CbGeAlD
Paliperidone—CYP2D6—central nervous system—systemic lupus erythematosus	0.00046	0.00396	CbGeAlD
Paliperidone—Vision blurred—Prednisone—systemic lupus erythematosus	0.000186	0.000484	CcSEcCtD
Paliperidone—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000186	0.000483	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000186	0.000483	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000185	0.000482	CcSEcCtD
Paliperidone—Pain—Hydrocortisone—systemic lupus erythematosus	0.000185	0.000481	CcSEcCtD
Paliperidone—Oedema—Betamethasone—systemic lupus erythematosus	0.000185	0.000481	CcSEcCtD
Paliperidone—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000185	0.000481	CcSEcCtD
Paliperidone—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000185	0.000481	CcSEcCtD
Paliperidone—Oedema—Dexamethasone—systemic lupus erythematosus	0.000185	0.000481	CcSEcCtD
Paliperidone—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000184	0.000479	CcSEcCtD
Paliperidone—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000184	0.000478	CcSEcCtD
Paliperidone—Infection—Betamethasone—systemic lupus erythematosus	0.000184	0.000478	CcSEcCtD
Paliperidone—Infection—Dexamethasone—systemic lupus erythematosus	0.000184	0.000478	CcSEcCtD
Paliperidone—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000183	0.000476	CcSEcCtD
Paliperidone—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000183	0.000476	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000183	0.000475	CcSEcCtD
Paliperidone—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000183	0.000475	CcSEcCtD
Paliperidone—Anaemia—Prednisone—systemic lupus erythematosus	0.000183	0.000474	CcSEcCtD
Paliperidone—Shock—Dexamethasone—systemic lupus erythematosus	0.000182	0.000473	CcSEcCtD
Paliperidone—Shock—Betamethasone—systemic lupus erythematosus	0.000182	0.000473	CcSEcCtD
Paliperidone—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000182	0.000473	CcSEcCtD
Paliperidone—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000181	0.000472	CcSEcCtD
Paliperidone—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000181	0.000472	CcSEcCtD
Paliperidone—Agitation—Prednisone—systemic lupus erythematosus	0.000181	0.000472	CcSEcCtD
Paliperidone—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000181	0.000471	CcSEcCtD
Paliperidone—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000181	0.000471	CcSEcCtD
Paliperidone—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000181	0.000469	CcSEcCtD
Paliperidone—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000181	0.000469	CcSEcCtD
Paliperidone—Angioedema—Prednisone—systemic lupus erythematosus	0.00018	0.000469	CcSEcCtD
Paliperidone—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.00018	0.000467	CcSEcCtD
Paliperidone—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.00018	0.000467	CcSEcCtD
Paliperidone—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000179	0.000466	CcSEcCtD
Paliperidone—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000178	0.000464	CcSEcCtD
Paliperidone—Malaise—Prednisone—systemic lupus erythematosus	0.000178	0.000463	CcSEcCtD
Paliperidone—Vertigo—Prednisone—systemic lupus erythematosus	0.000177	0.000461	CcSEcCtD
Paliperidone—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000177	0.00046	CcSEcCtD
Paliperidone—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000177	0.00046	CcSEcCtD
Paliperidone—Syncope—Prednisone—systemic lupus erythematosus	0.000177	0.00046	CcSEcCtD
Paliperidone—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000177	0.000459	CcSEcCtD
Paliperidone—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000176	0.000458	CcSEcCtD
Paliperidone—Anorexia—Betamethasone—systemic lupus erythematosus	0.000176	0.000458	CcSEcCtD
Paliperidone—Urticaria—Prednisolone—systemic lupus erythematosus	0.000176	0.000458	CcSEcCtD
Paliperidone—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000176	0.000457	CcSEcCtD
Paliperidone—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000176	0.000457	CcSEcCtD
Paliperidone—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000175	0.000456	CcSEcCtD
Paliperidone—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000175	0.000455	CcSEcCtD
Paliperidone—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000175	0.000454	CcSEcCtD
Paliperidone—Pain—Triamcinolone—systemic lupus erythematosus	0.000174	0.000453	CcSEcCtD
Paliperidone—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000174	0.000451	CcSEcCtD
Paliperidone—Hypotension—Betamethasone—systemic lupus erythematosus	0.000173	0.000449	CcSEcCtD
Paliperidone—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000173	0.000449	CcSEcCtD
Paliperidone—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000172	0.000448	CcSEcCtD
Paliperidone—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000172	0.000447	CcSEcCtD
Paliperidone—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000172	0.000447	CcSEcCtD
Paliperidone—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000171	0.000445	CcSEcCtD
Paliperidone—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000171	0.000445	CcSEcCtD
Paliperidone—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000171	0.000445	CcSEcCtD
Paliperidone—Convulsion—Prednisone—systemic lupus erythematosus	0.000171	0.000445	CcSEcCtD
Paliperidone—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000171	0.000444	CcSEcCtD
Paliperidone—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000171	0.000443	CcSEcCtD
Paliperidone—Hypertension—Prednisone—systemic lupus erythematosus	0.00017	0.000443	CcSEcCtD
Paliperidone—Chills—Methotrexate—systemic lupus erythematosus	0.00017	0.000442	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000169	0.000438	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000169	0.000438	CcSEcCtD
Paliperidone—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000168	0.000437	CcSEcCtD
Paliperidone—Myalgia—Prednisone—systemic lupus erythematosus	0.000168	0.000437	CcSEcCtD
Paliperidone—Arthralgia—Prednisone—systemic lupus erythematosus	0.000168	0.000437	CcSEcCtD
Paliperidone—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000168	0.000437	CcSEcCtD
Paliperidone—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000168	0.000436	CcSEcCtD
Paliperidone—Anxiety—Prednisone—systemic lupus erythematosus	0.000168	0.000435	CcSEcCtD
Paliperidone—Alopecia—Methotrexate—systemic lupus erythematosus	0.000168	0.000435	CcSEcCtD
Paliperidone—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000167	0.000435	CcSEcCtD
Paliperidone—Insomnia—Betamethasone—systemic lupus erythematosus	0.000167	0.000435	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000167	0.000434	CcSEcCtD
Paliperidone—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000167	0.000433	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000166	0.000432	CcSEcCtD
Paliperidone—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000166	0.000432	CcSEcCtD
Paliperidone—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000166	0.000432	CcSEcCtD
Paliperidone—Discomfort—Prednisone—systemic lupus erythematosus	0.000166	0.000432	CcSEcCtD
Paliperidone—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000166	0.000432	CcSEcCtD
Paliperidone—Erythema—Methotrexate—systemic lupus erythematosus	0.000165	0.000429	CcSEcCtD
Paliperidone—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000165	0.000429	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000163	0.000425	CcSEcCtD
Paliperidone—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000163	0.000423	CcSEcCtD
Paliperidone—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000163	0.000423	CcSEcCtD
Paliperidone—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000163	0.000423	CcSEcCtD
Paliperidone—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000162	0.000421	CcSEcCtD
Paliperidone—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000162	0.00042	CcSEcCtD
Paliperidone—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000162	0.00042	CcSEcCtD
Paliperidone—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000161	0.000419	CcSEcCtD
Paliperidone—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000161	0.000419	CcSEcCtD
Paliperidone—Oedema—Prednisone—systemic lupus erythematosus	0.000161	0.000419	CcSEcCtD
Paliperidone—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000161	0.000419	CcSEcCtD
Paliperidone—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000161	0.000418	CcSEcCtD
Paliperidone—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000161	0.000418	CcSEcCtD
Paliperidone—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000161	0.000418	CcSEcCtD
Paliperidone—Infection—Prednisone—systemic lupus erythematosus	0.00016	0.000416	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.00016	0.000415	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.00016	0.000415	CcSEcCtD
Paliperidone—Back pain—Methotrexate—systemic lupus erythematosus	0.00016	0.000415	CcSEcCtD
Paliperidone—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.00016	0.000415	CcSEcCtD
Paliperidone—Fatigue—Betamethasone—systemic lupus erythematosus	0.00016	0.000415	CcSEcCtD
Paliperidone—Fatigue—Dexamethasone—systemic lupus erythematosus	0.00016	0.000415	CcSEcCtD
Paliperidone—Shock—Prednisone—systemic lupus erythematosus	0.000159	0.000412	CcSEcCtD
Paliperidone—Pain—Dexamethasone—systemic lupus erythematosus	0.000158	0.000411	CcSEcCtD
Paliperidone—Pain—Betamethasone—systemic lupus erythematosus	0.000158	0.000411	CcSEcCtD
Paliperidone—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000158	0.000411	CcSEcCtD
Paliperidone—Tachycardia—Prednisone—systemic lupus erythematosus	0.000157	0.000409	CcSEcCtD
Paliperidone—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000157	0.000409	CcSEcCtD
Paliperidone—Skin disorder—Prednisone—systemic lupus erythematosus	0.000157	0.000407	CcSEcCtD
Paliperidone—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000156	0.000404	CcSEcCtD
Paliperidone—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000155	0.000404	CcSEcCtD
Paliperidone—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000155	0.000403	CcSEcCtD
Paliperidone—Rash—Cyclosporine—systemic lupus erythematosus	0.000154	0.000399	CcSEcCtD
Paliperidone—Anorexia—Prednisone—systemic lupus erythematosus	0.000154	0.000399	CcSEcCtD
Paliperidone—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000154	0.000399	CcSEcCtD
Paliperidone—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000153	0.000398	CcSEcCtD
Paliperidone—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000153	0.000398	CcSEcCtD
Paliperidone—Headache—Cyclosporine—systemic lupus erythematosus	0.000153	0.000397	CcSEcCtD
Paliperidone—Anaemia—Methotrexate—systemic lupus erythematosus	0.000153	0.000396	CcSEcCtD
Paliperidone—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000152	0.000396	CcSEcCtD
Paliperidone—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000152	0.000396	CcSEcCtD
Paliperidone—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000151	0.000393	CcSEcCtD
Paliperidone—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000151	0.000393	CcSEcCtD
Paliperidone—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000151	0.000393	CcSEcCtD
Paliperidone—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.00015	0.000391	CcSEcCtD
Paliperidone—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.00015	0.00039	CcSEcCtD
Paliperidone—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.00015	0.00039	CcSEcCtD
Paliperidone—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00015	0.000389	CcSEcCtD
Paliperidone—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000149	0.000387	CcSEcCtD
Paliperidone—Malaise—Methotrexate—systemic lupus erythematosus	0.000149	0.000387	CcSEcCtD
Paliperidone—Vertigo—Methotrexate—systemic lupus erythematosus	0.000148	0.000385	CcSEcCtD
Paliperidone—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000148	0.000385	CcSEcCtD
Paliperidone—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000148	0.000384	CcSEcCtD
Paliperidone—Urticaria—Betamethasone—systemic lupus erythematosus	0.000147	0.000382	CcSEcCtD
Paliperidone—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000147	0.000382	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000147	0.000382	CcSEcCtD
Paliperidone—Dizziness—Prednisolone—systemic lupus erythematosus	0.000147	0.000381	CcSEcCtD
Paliperidone—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000146	0.00038	CcSEcCtD
Paliperidone—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000146	0.00038	CcSEcCtD
Paliperidone—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000146	0.00038	CcSEcCtD
Paliperidone—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000146	0.00038	CcSEcCtD
Paliperidone—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000146	0.00038	CcSEcCtD
Paliperidone—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000146	0.000379	CcSEcCtD
Paliperidone—Insomnia—Prednisone—systemic lupus erythematosus	0.000146	0.000379	CcSEcCtD
Paliperidone—Nausea—Cyclosporine—systemic lupus erythematosus	0.000145	0.000376	CcSEcCtD
Paliperidone—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000145	0.000376	CcSEcCtD
Paliperidone—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000144	0.000375	CcSEcCtD
Paliperidone—Cough—Methotrexate—systemic lupus erythematosus	0.000144	0.000374	CcSEcCtD
Paliperidone—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000144	0.000374	CcSEcCtD
Paliperidone—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000143	0.000372	CcSEcCtD
Paliperidone—Convulsion—Methotrexate—systemic lupus erythematosus	0.000143	0.000372	CcSEcCtD
Paliperidone—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000142	0.000369	CcSEcCtD
Paliperidone—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000141	0.000367	CcSEcCtD
Paliperidone—Chest pain—Methotrexate—systemic lupus erythematosus	0.00014	0.000365	CcSEcCtD
Paliperidone—Arthralgia—Methotrexate—systemic lupus erythematosus	0.00014	0.000365	CcSEcCtD
Paliperidone—Myalgia—Methotrexate—systemic lupus erythematosus	0.00014	0.000365	CcSEcCtD
Paliperidone—Decreased appetite—Prednisone—systemic lupus erythematosus	0.00014	0.000364	CcSEcCtD
Paliperidone—Rash—Prednisolone—systemic lupus erythematosus	0.00014	0.000363	CcSEcCtD
Paliperidone—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00014	0.000363	CcSEcCtD
Paliperidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.00014	0.000363	CcSEcCtD
Paliperidone—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000139	0.000362	CcSEcCtD
Paliperidone—Fatigue—Prednisone—systemic lupus erythematosus	0.000139	0.000361	CcSEcCtD
Paliperidone—Headache—Prednisolone—systemic lupus erythematosus	0.000139	0.000361	CcSEcCtD
Paliperidone—Discomfort—Methotrexate—systemic lupus erythematosus	0.000139	0.000361	CcSEcCtD
Paliperidone—Constipation—Prednisone—systemic lupus erythematosus	0.000138	0.000358	CcSEcCtD
Paliperidone—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000138	0.000358	CcSEcCtD
Paliperidone—Rash—Hydrocortisone—systemic lupus erythematosus	0.000137	0.000355	CcSEcCtD
Paliperidone—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000136	0.000355	CcSEcCtD
Paliperidone—Confusional state—Methotrexate—systemic lupus erythematosus	0.000136	0.000353	CcSEcCtD
Paliperidone—Headache—Hydrocortisone—systemic lupus erythematosus	0.000136	0.000353	CcSEcCtD
Paliperidone—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000135	0.000351	CcSEcCtD
Paliperidone—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000135	0.00035	CcSEcCtD
Paliperidone—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000135	0.00035	CcSEcCtD
Paliperidone—Infection—Methotrexate—systemic lupus erythematosus	0.000134	0.000348	CcSEcCtD
Paliperidone—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000133	0.000345	CcSEcCtD
Paliperidone—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000133	0.000345	CcSEcCtD
Paliperidone—Asthenia—Betamethasone—systemic lupus erythematosus	0.000133	0.000345	CcSEcCtD
Paliperidone—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000132	0.000343	CcSEcCtD
Paliperidone—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000132	0.000343	CcSEcCtD
Paliperidone—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000132	0.000342	CcSEcCtD
Paliperidone—Nausea—Prednisolone—systemic lupus erythematosus	0.000132	0.000342	CcSEcCtD
Paliperidone—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000131	0.00034	CcSEcCtD
Paliperidone—Pruritus—Betamethasone—systemic lupus erythematosus	0.000131	0.00034	CcSEcCtD
Paliperidone—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000131	0.00034	CcSEcCtD
Paliperidone—Vomiting—Triamcinolone—systemic lupus erythematosus	0.00013	0.000337	CcSEcCtD
Paliperidone—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000129	0.000336	CcSEcCtD
Paliperidone—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000129	0.000334	CcSEcCtD
Paliperidone—Rash—Triamcinolone—systemic lupus erythematosus	0.000129	0.000334	CcSEcCtD
Paliperidone—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000128	0.000334	CcSEcCtD
Paliperidone—Anorexia—Methotrexate—systemic lupus erythematosus	0.000128	0.000334	CcSEcCtD
Paliperidone—Rash—Methylprednisolone—systemic lupus erythematosus	0.000128	0.000333	CcSEcCtD
Paliperidone—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000128	0.000333	CcSEcCtD
Paliperidone—Urticaria—Prednisone—systemic lupus erythematosus	0.000128	0.000333	CcSEcCtD
Paliperidone—Headache—Triamcinolone—systemic lupus erythematosus	0.000128	0.000332	CcSEcCtD
Paliperidone—Headache—Methylprednisolone—systemic lupus erythematosus	0.000127	0.000331	CcSEcCtD
Paliperidone—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000127	0.000331	CcSEcCtD
Paliperidone—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000127	0.000331	CcSEcCtD
Paliperidone—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000127	0.000329	CcSEcCtD
Paliperidone—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000127	0.000329	CcSEcCtD
Paliperidone—Hypotension—Methotrexate—systemic lupus erythematosus	0.000126	0.000327	CcSEcCtD
Paliperidone—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000123	0.000319	CcSEcCtD
Paliperidone—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000122	0.000318	CcSEcCtD
Paliperidone—Dizziness—Betamethasone—systemic lupus erythematosus	0.000122	0.000318	CcSEcCtD
Paliperidone—Insomnia—Methotrexate—systemic lupus erythematosus	0.000122	0.000317	CcSEcCtD
Paliperidone—Nausea—Triamcinolone—systemic lupus erythematosus	0.000121	0.000315	CcSEcCtD
Paliperidone—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000121	0.000314	CcSEcCtD
Paliperidone—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000121	0.000314	CcSEcCtD
Paliperidone—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.00012	0.000312	CcSEcCtD
Paliperidone—Somnolence—Methotrexate—systemic lupus erythematosus	0.00012	0.000311	CcSEcCtD
Paliperidone—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000119	0.000309	CcSEcCtD
Paliperidone—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000119	0.000308	CcSEcCtD
Paliperidone—Vomiting—Betamethasone—systemic lupus erythematosus	0.000118	0.000306	CcSEcCtD
Paliperidone—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000118	0.000306	CcSEcCtD
Paliperidone—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000117	0.000304	CcSEcCtD
Paliperidone—Rash—Dexamethasone—systemic lupus erythematosus	0.000117	0.000303	CcSEcCtD
Paliperidone—Rash—Betamethasone—systemic lupus erythematosus	0.000117	0.000303	CcSEcCtD
Paliperidone—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000117	0.000303	CcSEcCtD
Paliperidone—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000117	0.000303	CcSEcCtD
Paliperidone—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000116	0.000302	CcSEcCtD
Paliperidone—Fatigue—Methotrexate—systemic lupus erythematosus	0.000116	0.000302	CcSEcCtD
Paliperidone—Headache—Betamethasone—systemic lupus erythematosus	0.000116	0.000301	CcSEcCtD
Paliperidone—Headache—Dexamethasone—systemic lupus erythematosus	0.000116	0.000301	CcSEcCtD
Paliperidone—Asthenia—Prednisone—systemic lupus erythematosus	0.000116	0.0003	CcSEcCtD
Paliperidone—Pain—Methotrexate—systemic lupus erythematosus	0.000115	0.000299	CcSEcCtD
Paliperidone—Pruritus—Prednisone—systemic lupus erythematosus	0.000114	0.000296	CcSEcCtD
Paliperidone—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000111	0.000288	CcSEcCtD
Paliperidone—Diarrhoea—Prednisone—systemic lupus erythematosus	0.00011	0.000287	CcSEcCtD
Paliperidone—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.00011	0.000286	CcSEcCtD
Paliperidone—Nausea—Betamethasone—systemic lupus erythematosus	0.00011	0.000286	CcSEcCtD
Paliperidone—Nausea—Dexamethasone—systemic lupus erythematosus	0.00011	0.000286	CcSEcCtD
Paliperidone—Urticaria—Methotrexate—systemic lupus erythematosus	0.000107	0.000278	CcSEcCtD
Paliperidone—Dizziness—Prednisone—systemic lupus erythematosus	0.000107	0.000277	CcSEcCtD
Paliperidone—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000106	0.000277	CcSEcCtD
Paliperidone—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000106	0.000277	CcSEcCtD
Paliperidone—Vomiting—Prednisone—systemic lupus erythematosus	0.000102	0.000266	CcSEcCtD
Paliperidone—Rash—Prednisone—systemic lupus erythematosus	0.000102	0.000264	CcSEcCtD
Paliperidone—Dermatitis—Prednisone—systemic lupus erythematosus	0.000102	0.000264	CcSEcCtD
Paliperidone—Headache—Prednisone—systemic lupus erythematosus	0.000101	0.000262	CcSEcCtD
Paliperidone—Hypersensitivity—Methotrexate—systemic lupus erythematosus	9.92e-05	0.000258	CcSEcCtD
Paliperidone—Asthenia—Methotrexate—systemic lupus erythematosus	9.66e-05	0.000251	CcSEcCtD
Paliperidone—Nausea—Prednisone—systemic lupus erythematosus	9.57e-05	0.000249	CcSEcCtD
Paliperidone—Pruritus—Methotrexate—systemic lupus erythematosus	9.53e-05	0.000248	CcSEcCtD
Paliperidone—Diarrhoea—Methotrexate—systemic lupus erythematosus	9.22e-05	0.000239	CcSEcCtD
Paliperidone—Dizziness—Methotrexate—systemic lupus erythematosus	8.91e-05	0.000231	CcSEcCtD
Paliperidone—Vomiting—Methotrexate—systemic lupus erythematosus	8.56e-05	0.000223	CcSEcCtD
Paliperidone—Rash—Methotrexate—systemic lupus erythematosus	8.49e-05	0.000221	CcSEcCtD
Paliperidone—Dermatitis—Methotrexate—systemic lupus erythematosus	8.48e-05	0.00022	CcSEcCtD
Paliperidone—Headache—Methotrexate—systemic lupus erythematosus	8.44e-05	0.000219	CcSEcCtD
Paliperidone—Nausea—Methotrexate—systemic lupus erythematosus	8e-05	0.000208	CcSEcCtD
Paliperidone—ADRA2C—Metabolism—PPARG—systemic lupus erythematosus	8.21e-06	0.000216	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—NOS3—systemic lupus erythematosus	8.18e-06	0.000215	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—JAK1—systemic lupus erythematosus	8.16e-06	0.000214	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TYK2—systemic lupus erythematosus	8.16e-06	0.000214	CbGpPWpGaD
Paliperidone—ADRA1A—GPCR downstream signaling—IL2—systemic lupus erythematosus	8.16e-06	0.000214	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—JAK1—systemic lupus erythematosus	8.15e-06	0.000214	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TYK2—systemic lupus erythematosus	8.03e-06	0.000211	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	8.03e-06	0.000211	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—NOS3—systemic lupus erythematosus	8.01e-06	0.00021	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—JAK1—systemic lupus erythematosus	7.99e-06	0.00021	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CCL2—systemic lupus erythematosus	7.96e-06	0.000209	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—F2—systemic lupus erythematosus	7.96e-06	0.000209	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—NOS3—systemic lupus erythematosus	7.88e-06	0.000207	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCR5—systemic lupus erythematosus	7.86e-06	0.000206	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CCL2—systemic lupus erythematosus	7.86e-06	0.000206	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.75e-06	0.000203	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCR5—systemic lupus erythematosus	7.74e-06	0.000203	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCR5—systemic lupus erythematosus	7.72e-06	0.000203	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL2—systemic lupus erythematosus	7.69e-06	0.000202	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—C3—systemic lupus erythematosus	7.68e-06	0.000202	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—F2—systemic lupus erythematosus	7.68e-06	0.000202	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—F2—systemic lupus erythematosus	7.64e-06	0.000201	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CD80—systemic lupus erythematosus	7.63e-06	0.0002	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.62e-06	0.0002	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.61e-06	0.0002	CbGpPWpGaD
Paliperidone—ADRA2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	7.58e-06	0.000199	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCR5—systemic lupus erythematosus	7.57e-06	0.000199	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL2—systemic lupus erythematosus	7.57e-06	0.000199	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—C3—systemic lupus erythematosus	7.56e-06	0.000198	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL2—systemic lupus erythematosus	7.55e-06	0.000198	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—C3—systemic lupus erythematosus	7.54e-06	0.000198	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL2RA—systemic lupus erythematosus	7.47e-06	0.000196	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—F2—systemic lupus erythematosus	7.43e-06	0.000195	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—JAK1—systemic lupus erythematosus	7.43e-06	0.000195	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL2—systemic lupus erythematosus	7.41e-06	0.000195	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—C3—systemic lupus erythematosus	7.4e-06	0.000194	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—ALB—systemic lupus erythematosus	7.38e-06	0.000194	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CD80—systemic lupus erythematosus	7.37e-06	0.000193	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CD80—systemic lupus erythematosus	7.33e-06	0.000192	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—F2—systemic lupus erythematosus	7.32e-06	0.000192	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TYK2—systemic lupus erythematosus	7.23e-06	0.00019	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TYK2—systemic lupus erythematosus	7.13e-06	0.000187	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CD80—systemic lupus erythematosus	7.13e-06	0.000187	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—NOS3—systemic lupus erythematosus	7.1e-06	0.000186	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CCL2—systemic lupus erythematosus	7.09e-06	0.000186	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	7.09e-06	0.000186	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—NOS3—systemic lupus erythematosus	7.06e-06	0.000185	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCR5—systemic lupus erythematosus	7.04e-06	0.000185	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CD80—systemic lupus erythematosus	7.01e-06	0.000184	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—NOS3—systemic lupus erythematosus	7e-06	0.000184	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.94e-06	0.000182	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	6.94e-06	0.000182	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL2—systemic lupus erythematosus	6.94e-06	0.000182	CbGpPWpGaD
Paliperidone—HTR1D—Signaling by GPCR—IL6—systemic lupus erythematosus	6.9e-06	0.000181	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	6.88e-06	0.000181	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	6.88e-06	0.000181	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—C3—systemic lupus erythematosus	6.88e-06	0.000181	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CCL2—systemic lupus erythematosus	6.85e-06	0.00018	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.83e-06	0.000179	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CCL2—systemic lupus erythematosus	6.81e-06	0.000179	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL2—systemic lupus erythematosus	6.79e-06	0.000178	CbGpPWpGaD
Paliperidone—HTR1B—Signaling by GPCR—IL6—systemic lupus erythematosus	6.76e-06	0.000177	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—F2—systemic lupus erythematosus	6.75e-06	0.000177	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL2—systemic lupus erythematosus	6.68e-06	0.000175	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PPARG—systemic lupus erythematosus	6.67e-06	0.000175	CbGpPWpGaD
Paliperidone—DRD4—Signaling by GPCR—IL6—systemic lupus erythematosus	6.65e-06	0.000175	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—F2—systemic lupus erythematosus	6.64e-06	0.000174	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CCL2—systemic lupus erythematosus	6.63e-06	0.000174	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—F2—systemic lupus erythematosus	6.62e-06	0.000174	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—MMP9—systemic lupus erythematosus	6.56e-06	0.000172	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.54e-06	0.000172	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CCL2—systemic lupus erythematosus	6.52e-06	0.000171	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—F2—systemic lupus erythematosus	6.5e-06	0.000171	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CD80—systemic lupus erythematosus	6.47e-06	0.00017	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—PTGS2—systemic lupus erythematosus	6.46e-06	0.00017	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TYK2—systemic lupus erythematosus	6.44e-06	0.000169	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—MMP9—systemic lupus erythematosus	6.43e-06	0.000169	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.4e-06	0.000168	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	6.36e-06	0.000167	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CD80—systemic lupus erythematosus	6.35e-06	0.000167	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—MMP9—systemic lupus erythematosus	6.33e-06	0.000166	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—NOS3—systemic lupus erythematosus	6.32e-06	0.000166	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.3e-06	0.000165	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	6.23e-06	0.000164	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—EP300—systemic lupus erythematosus	6.22e-06	0.000163	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TYK2—systemic lupus erythematosus	6.22e-06	0.000163	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	6.19e-06	0.000162	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.15e-06	0.000161	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	6.11e-06	0.00016	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—NOS3—systemic lupus erythematosus	6.1e-06	0.00016	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—EP300—systemic lupus erythematosus	6.09e-06	0.00016	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	6.07e-06	0.000159	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.07e-06	0.000159	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	6.04e-06	0.000159	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL2—systemic lupus erythematosus	6.02e-06	0.000158	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TYK2—systemic lupus erythematosus	6.02e-06	0.000158	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	6.01e-06	0.000158	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	6e-06	0.000157	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—EP300—systemic lupus erythematosus	6e-06	0.000157	CbGpPWpGaD
Paliperidone—DRD1—Signaling by GPCR—IL6—systemic lupus erythematosus	5.99e-06	0.000157	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL2—systemic lupus erythematosus	5.94e-06	0.000156	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	5.92e-06	0.000155	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	5.92e-06	0.000155	CbGpPWpGaD
Paliperidone—DRD3—Signaling by GPCR—IL6—systemic lupus erythematosus	5.91e-06	0.000155	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—NOS3—systemic lupus erythematosus	5.91e-06	0.000155	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CCL2—systemic lupus erythematosus	5.9e-06	0.000155	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.89e-06	0.000155	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	5.81e-06	0.000153	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	5.79e-06	0.000152	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	5.79e-06	0.000152	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.77e-06	0.000152	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	5.74e-06	0.000151	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—MMP9—systemic lupus erythematosus	5.69e-06	0.00015	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.68e-06	0.000149	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.67e-06	0.000149	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—MMP9—systemic lupus erythematosus	5.62e-06	0.000148	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.6e-06	0.000147	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	5.5e-06	0.000144	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.48e-06	0.000144	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	5.46e-06	0.000143	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.41e-06	0.000142	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—EP300—systemic lupus erythematosus	5.4e-06	0.000142	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	5.38e-06	0.000141	CbGpPWpGaD
Paliperidone—ADRA2C—Metabolism—EP300—systemic lupus erythematosus	5.37e-06	0.000141	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	5.37e-06	0.000141	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TYK2—systemic lupus erythematosus	5.36e-06	0.000141	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL2—systemic lupus erythematosus	5.36e-06	0.000141	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	5.36e-06	0.000141	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	5.33e-06	0.00014	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—EP300—systemic lupus erythematosus	5.33e-06	0.00014	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.3e-06	0.000139	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.29e-06	0.000139	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	5.27e-06	0.000138	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—NOS3—systemic lupus erythematosus	5.26e-06	0.000138	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	5.26e-06	0.000138	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.26e-06	0.000138	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	5.26e-06	0.000138	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	5.25e-06	0.000138	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.21e-06	0.000137	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL2—systemic lupus erythematosus	5.17e-06	0.000136	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	5.16e-06	0.000136	CbGpPWpGaD
Paliperidone—HTR1A—Signaling by GPCR—IL6—systemic lupus erythematosus	5.15e-06	0.000135	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	5.15e-06	0.000135	CbGpPWpGaD
Paliperidone—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	5.12e-06	0.000134	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.12e-06	0.000134	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.11e-06	0.000134	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	5.07e-06	0.000133	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.05e-06	0.000133	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.05e-06	0.000132	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.03e-06	0.000132	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL2—systemic lupus erythematosus	5.01e-06	0.000131	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling by GPCR—IL6—systemic lupus erythematosus	4.98e-06	0.000131	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	4.93e-06	0.000129	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	4.9e-06	0.000129	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—MMP9—systemic lupus erythematosus	4.9e-06	0.000129	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.89e-06	0.000128	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.88e-06	0.000128	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	4.87e-06	0.000128	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.85e-06	0.000127	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—EP300—systemic lupus erythematosus	4.81e-06	0.000126	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	4.81e-06	0.000126	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.8e-06	0.000126	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—MMP9—systemic lupus erythematosus	4.74e-06	0.000124	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.72e-06	0.000124	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.69e-06	0.000123	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	4.66e-06	0.000122	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.65e-06	0.000122	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—EP300—systemic lupus erythematosus	4.64e-06	0.000122	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.64e-06	0.000122	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.63e-06	0.000122	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	4.62e-06	0.000121	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.57e-06	0.00012	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.56e-06	0.00012	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.55e-06	0.00012	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	4.54e-06	0.000119	CbGpPWpGaD
Paliperidone—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	4.52e-06	0.000119	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	4.5e-06	0.000118	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—EP300—systemic lupus erythematosus	4.49e-06	0.000118	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.47e-06	0.000117	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	4.47e-06	0.000117	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL2—systemic lupus erythematosus	4.46e-06	0.000117	CbGpPWpGaD
Paliperidone—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	4.45e-06	0.000117	CbGpPWpGaD
Paliperidone—HRH1—Signaling by GPCR—IL6—systemic lupus erythematosus	4.44e-06	0.000117	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	4.42e-06	0.000116	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.4e-06	0.000115	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	4.38e-06	0.000115	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.37e-06	0.000115	CbGpPWpGaD
Paliperidone—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	4.36e-06	0.000115	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	4.35e-06	0.000114	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	4.35e-06	0.000114	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	4.3e-06	0.000113	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.28e-06	0.000112	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.25e-06	0.000112	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	4.23e-06	0.000111	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—MMP9—systemic lupus erythematosus	4.22e-06	0.000111	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.22e-06	0.000111	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.21e-06	0.00011	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.19e-06	0.00011	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.18e-06	0.00011	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.16e-06	0.000109	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	4.14e-06	0.000109	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.13e-06	0.000108	CbGpPWpGaD
Paliperidone—HTR1D—Signaling Pathways—IL6—systemic lupus erythematosus	4.08e-06	0.000107	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	4.08e-06	0.000107	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	4.07e-06	0.000107	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	4.05e-06	0.000106	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.04e-06	0.000106	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.01e-06	0.000105	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	4.01e-06	0.000105	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—EP300—systemic lupus erythematosus	4e-06	0.000105	CbGpPWpGaD
Paliperidone—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	4e-06	0.000105	CbGpPWpGaD
Paliperidone—HTR1B—Signaling Pathways—IL6—systemic lupus erythematosus	3.99e-06	0.000105	CbGpPWpGaD
Paliperidone—DRD4—Signaling Pathways—IL6—systemic lupus erythematosus	3.93e-06	0.000103	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	3.93e-06	0.000103	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	3.91e-06	0.000103	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.91e-06	0.000103	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.86e-06	0.000101	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.85e-06	0.000101	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.84e-06	0.000101	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.83e-06	0.000101	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.8e-06	9.97e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.79e-06	9.95e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	3.74e-06	9.82e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.72e-06	9.77e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	3.65e-06	9.58e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.54e-06	9.3e-05	CbGpPWpGaD
Paliperidone—DRD1—Signaling Pathways—IL6—systemic lupus erythematosus	3.54e-06	9.29e-05	CbGpPWpGaD
Paliperidone—DRD3—Signaling Pathways—IL6—systemic lupus erythematosus	3.49e-06	9.16e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.49e-06	9.15e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.48e-06	9.13e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.46e-06	9.07e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	3.42e-06	8.98e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.41e-06	8.96e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.17e-06	8.33e-05	CbGpPWpGaD
Paliperidone—ADRA2B—Signaling Pathways—IL6—systemic lupus erythematosus	3.15e-06	8.27e-05	CbGpPWpGaD
Paliperidone—HTR1A—Signaling Pathways—IL6—systemic lupus erythematosus	3.04e-06	7.98e-05	CbGpPWpGaD
Paliperidone—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	3.03e-06	7.94e-05	CbGpPWpGaD
Paliperidone—ADRA2C—Signaling Pathways—IL6—systemic lupus erythematosus	2.94e-06	7.73e-05	CbGpPWpGaD
Paliperidone—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	2.9e-06	7.6e-05	CbGpPWpGaD
Paliperidone—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	2.84e-06	7.47e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.84e-06	7.46e-05	CbGpPWpGaD
Paliperidone—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	2.67e-06	7.01e-05	CbGpPWpGaD
Paliperidone—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	2.63e-06	6.9e-05	CbGpPWpGaD
Paliperidone—HRH1—Signaling Pathways—IL6—systemic lupus erythematosus	2.62e-06	6.88e-05	CbGpPWpGaD
Paliperidone—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	2.57e-06	6.75e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.56e-06	6.71e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.44e-06	6.42e-05	CbGpPWpGaD
Paliperidone—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	2.39e-06	6.28e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.24e-06	5.87e-05	CbGpPWpGaD
Paliperidone—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.86e-06	4.88e-05	CbGpPWpGaD
